452-08-4
452-08-4
Chemical Structure
2-Bromo-4-fluoroanisole
- CAS No.: 452-08-4
- Formula:C7H6BrFO
- Molecular Weight:205.03
IUPAC Name: 2-bromo-4-fluoro-1-methoxybenzene
InChIKey: JIQXVIJARQLCOY-UHFFFAOYSA-N
SMILES: COC1=C(Br)C=C(F)C=C1
Biological Activity: 2-Bromo-4-fluoroanisole is an important intermediate in organic synthesis. 2-Bromo-4-fluoroanisole can be used in the research of diabetic complications (including blindness)[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2-Bromo-4-fluoroanisole | 99.69% | 2-Bromo-4-fluoroanisole is an important intermediate in organic synthesis. 2-Bromo-4-fluoroanisole can be used in the research of diabetic complications (including blindness). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. de la Fuente JA, et al. Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product. J Med Chem. 2003 Nov 20;46(24):5208-21. [Content Brief]
- [2]. Edwards JP, et al. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents. J Med Chem. 1998 Jan 29;41(3):303-10. [Content Brief]
- [3]. Betageri R, et al. Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4761-9. [Content Brief]
Keywords
